$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Anti-angiogenic compositions and methods of use 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
출원번호 US-0294458 (1999-04-19)
우선권정보 WO-PCT/CA94/00373 (1994-07-19)
발명자 / 주소
  • Hunter, William L.
  • Machan, Lindsay S.
  • Arsenault, A. Larry
출원인 / 주소
  • Angiotech Pharmaceuticals, Inc.
대리인 / 주소
    SEED Intellectual Property Law Group PLLC
인용정보 피인용 횟수 : 108  인용 특허 : 120

초록

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also, provided are methods for embolizing blood vessels,

대표청구항

1. A composition, comprising: (a) a compound which disrupts microtubule function; and (b) a non-biodegradable polymer. 2. The composition according to claim 1 wherein said compound is paclitaxel or derivative thereof. 3. The composition according to claim 1 wherein said compound is colchicine.

이 특허에 인용된 특허 (120)

  1. Chen Shu-Hui (Hamden CT) Farina Vittorio (West Hartford CT) Roth Gregory (Cheshire CT) Kadow John (Wallingford CT), 6,7-modified paclitaxels.
  2. Shaw Jack M. (Alcon Laboratories ; 6201 S. Freeway ; R2-45 Fort Worth TX 76134) Schook Lawrence B. (605 N. Hamilton Dr. Champagne IL 61820), Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host.
  3. Wittman Mark D. (Cheshire CT) Kadow John F. (Wallingford CT), Amino acid derivatives of paclitaxel.
  4. Kanoh Tamotsu (Chiba JPX) Matsunaga Kenichi (Tokorozawa JPX) Saito Kenichi (Tokyo JPX) Fujii Takayoshi (Tokyo JPX), Angiogenesis inhibitor.
  5. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic Compositions and methods for the treatment of arthritis.
  6. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  7. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  8. Bentzen Craig L. (Chavannes de Bogis CHX) Mong Lan N. (Nyon CHX) Niesor Eric (Gland CHX), Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds.
  9. Kuettner Klaus E. (Chicago IL), Anti-invasion factor containing cultures.
  10. Folkman Moses J. (Brookline MA) Chen Neil T. (Newton Center MA) Corey Elias J. (Cambridge MA), Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin.
  11. Wong Vernon G. (Rockville MD) Kochinke Frank (San Jose CA), Biocompatible ocular implants.
  12. Kohn Joachim (Brookline MA) Langer Robert S. (Somerville MA), Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article.
  13. Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods for producing the same.
  14. Silver Frederick A. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Birk David E. (Somerset NJ) Weadock Kevin (Piscataway NJ) Whyne Conrad (Somerset NJ), Biodegradable matrix and methods for producing same.
  15. Silver Frederick H. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Doillon Charles J. (Edison NJ) Weadock Kevin (Piscataway NJ) Whyne Conrad (Edgewood MD), Biodegradable matrix and methods for producing same.
  16. Langer Robert S. (Somerville MA) Rosen Howard (Montara CA) Linhardt Robert J. (Iowa City IA) Leong Kam (Cambridge MA), Bioerodible polyanhydrides for controlled drug delivery.
  17. Gerhart Tobin N. (Brockline MA) Laurencin Cato T. (Somerville MA) Domb Abraham J. (Baltimore MD) Langer Robert S. (Newton MA) Hayes Wilson C. (Lincoln MA), Bioerodible polymers for drug delivery in bone.
  18. Heller Jorge (Woodside CA) Ng Steve Y. W. (San Francisco CA), Bioerodible polymers for solid controlled release pharmaceutical compositions.
  19. Kossovsky Nir (Los Angeles CA) Hnatyszyn H. James (Los Angeles CA) Gelman Andrew (Los Angeles CA), Biological and pharmaceutical agents having a nanomeric biodegradable core.
  20. Kuettner Klaus E. (426B W. Webster Chicago IL 60614) Tripier Dominique (411 S. Sangamon ; #4D D-6239 Eppstein DEX) Brocks Dietrich (411 S. Sangamon ; #4D D-6200 Wiesbaden 42 IL DEX) DiMuzio Michael T, Cartilage-derived leukocyte elastase-inhibitor.
  21. Kuettner Klaus E. (426-B W. Webster Chicago IL 60614) Eisenstein Reuben (6708 N. Keating Lincolnwood IL 60646) Sorgente Nino (1832 Edgecliffe Dr. Los Angeles CA 90026), Cell proliferation and tissue invasion inhibitor.
  22. Whitbourne Richard J. (Fairport NY) Mangan Margaret A. (Rochester NY), Coating compositions comprising pharmaceutical agents.
  23. Mantelle Juan A. (Miami FL), Compositions and methods for topical administration of pharmaceutically active agents.
  24. Kopia Gregory A. (Phoenixville PA) Horan Paul K. (Downingtown PA) Gray Brian D. (Ardmore PA) Troutner David E. (Phoenixville PA) Muirhead Katharine A. (West Chester PA) Sheth Kamleshkumar A. (Downing, Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles.
  25. Park Tae G. (Cambridge MA) Cohen Smadar (Petach-Tickva MA ILX) Langer Robert S. (Newton MA), Controlled drug delivery using polymer/pluronic blends.
  26. Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  27. Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  28. Edelman Elazer R. (Brookline MA) Langer Robert S. (Somerville MA) Klagsburn Michael (Newton MA) Mathiowitz Edith (Brookline MA), Controlled release systems containing heparin and growth factors.
  29. Schaefer Hans (Antibes FRX) Watts Francine (Le Bar sur Loup FRX) Papantoniou Christos (Montmorency FRX) Mahieu Claude (Paris FRX), Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least o.
  30. Wood Louis L. (Rockville MD) Calton Gary J. (Elkridge MD), Cryogel oral pharmaceutical composition containing therapeutic agent.
  31. Ansell Christopher W. G. (Cambridge GBX) Butler Colin (Upper Boddington GBX), Curable compositions.
  32. Loftsson Thorsteinn (Reykjavik ISX), Cyclodextrin complexation.
  33. Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julianne (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
  34. Stella Valentino J. (Lawrence KS) Mathew Abraham E. (Lenexa KS), Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
  35. Chang Yunik (Toms River NJ) Patel Dinesh C. (Murray UT) Ebert Charles D. (Salt Lake City UT), Device for administering an active agent to the skin or mucosa.
  36. Carey Martin C. (Wellesley MA) Moses Alan C. (Waban MA) Flier Jeffrey S. (West Newton MA), Drug administration.
  37. Illum Lisbeth (Charlottenlund DKX), Drug delivery system.
  38. Balazs Endre A. (Ft. Lee NJ) Leshchiner Adolf (Fairview NJ) Larsen Nancy E. (Ridgefield Park NJ), Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same.
  39. Edelman Elazer R. (Brookline MA) Adams David H. (Boston MA) Karnovsky Morris J. (Newton Centre MA), Extraluminal regulation of the growth and repair of tubular structures in vivo.
  40. Edelman Elazer R. (Brookline MA) Adams David H. (Boston MA) Karnovsky Morris J. (Newton Centre MA), Extraluminal regulation of the growth and repair of tubular structures in vivo.
  41. Edelman Elazer R. (Brookline MA) Adams David H. (Boston MA) Karnovsky Morris J. (Newton Centre MA), Extraluminal regulation of the growth and repair of tubular structures in vivo.
  42. Balazs Endre A. (Riverdale NY) Leshchiner Adolf (Brooklyn NY), Hyaluronate modified polymeric articles.
  43. Cahalan Patrick T. (Champlin MN) Jevne Allan H. (Anoka MN) Coury Arthur J. (St. Paul MN) Kallok Michael J. (New Brighton MN), Hydrogel adhesive.
  44. Folkman Moses J. (Brookline MA) Taylor Stephanie (Boston MA) Langer Robert S. (Somerville MA), Inhibition of angiogenesis.
  45. Folkman Moses J. (Brookline) Taylor Stephanie (Boston) Langer Robert S. (Somerville MA), Inhibition of angiogenesis.
  46. Galardy Richard E. (73 Faulkner Dr. Suilford CT 06437), Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors.
  47. Braughler John M. (Portage MI) Hall Edward D. (Portage MI) McCall John M. (Kalamazoo MI) Wierenga Wendell (Oshtemo Township ; Kalamazoo County MI) Folkman Judah (Brookline MA 4), Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments.
  48. Kuettner Klaus E. (Chicago IL), Inhibition of bone resorption.
  49. Edelman Elazer R. ; Nathan Aruna ; Nugent Matthew A., Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells.
  50. Risau Werner (Grfelfing DEX) Drexler Hannes (Munich DEX), Inhibitor of the proliferation of endothelial cells.
  51. Tice, Thomas R.; Lewis, Danny H.; Cowsar, Donald R.; Beck, Lee R., Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
  52. Will Fritz (Hasselbusch DEX), Intracorporeal temporary wound closure.
  53. Okada Hiroaki (Suita) Kamei Shigeru (Takarazuka) Yoshioka Toshio (Nishinomiya JPX), Intravascular embolizing agent containing angiogenesis-inhibiting substance.
  54. Rahman Aquilur (Gaithersburg MD) Rafaeloff Rafael (Tel-Aviv MD ILX) Husain Syed R. (Gaithersburg MD), Liposome encapsulated taxol and a method of using the same.
  55. Whitbourne Richard J. (Fairport NY), Lubricious hydrophilic composite coated on substrates.
  56. Yoda Kiyoshi (Amagasaki JPX), Magnetic resonance apparatus.
  57. Viegas Tacey X. (Canton MI) Reeve Lorraine E. (Dexter MI) Henry Raymond L. (Grosse Pointe Woods MI), Medical uses of in situ formed gels.
  58. Fuller William D. (San Diego CA) Blair Robert K. (Oceanside CA) Goodman Murray (La Jolla CA), Metabolically acceptable polyisocyanate adhesives.
  59. Folkman Judah (Brookline MA) Fujita Takeshi (Takarazuka MA JPX) Ingber Donald (Boston MA) Kanamaru Tsuneo (Takatsuki JPX), Method and a pharmaceutical composition for the inhibition of angiogenesis.
  60. Gillespie Larrian (Brentwood CA), Method and composition for arresting angiogenesis and capillary, cell or membrane leakage.
  61. Leibovich Samuel J. (Skokie IL) Polverini Peter J. (Evanston IL) Shepard H. Michael (San Francisco CA), Method and compositions for modulating neovascularization.
  62. March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
  63. Thieler William R. (2175 Via Tuscany Winter Park FL 32789), Method for opening and closing surgical wounds.
  64. Folkman Moses J. (Brookline MA) Ingber Donald (Boston MA), Method for regressing angiogenesis using o-substituted fumagillol derivatives.
  65. Lane Irwin W. (Short Hills NJ), Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage.
  66. Presant Cary A. (San Marino CA) Proffitt Richard T. (Arcadia CA) Teplitz Raymond L. (Pasadena CA) Williams Lawrence E. (San Dimas CA) Tin George W. (Arcadia CA), Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body.
  67. Bouck Noel P. (Oak Park) Polverini Peter J. (Evanston) Good Deborah J. (Chicago IL) Rastinejad Farzan (Los Altos CA), Method of inhibiting angiogenesis of tumors.
  68. Lodge Nicholas J. (Hamilton Square NJ), Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing.
  69. Hsieh Dean S. T. (Cambridge MA) Langer ; Jr. Robert S. (Somerville MA), Method of making prolonged release body.
  70. Cilento Rodolfo D. (North Brunswick NJ) Frank Margaret A. (Lawrenceville NJ) Fairbrother John E. (Wales NJ GBX) Freeman Frank M. (Lawrenceville NJ), Method of preparing adhesive dressings containing a pharmaceutically active ingredient.
  71. Kinsella James L. (Baltimore MD) Sollott Steven J. (Baltimore MD), Method of treating atherosclerosis or restenosis using microtubule stabilizing agent.
  72. Sievers Robert E. (655 Northstar Ct. Boulder CO 80304) Hybertson Brooks M. (280 County Rd. 83 Boulder CO 80302) Hansen Brian N. (1510 Eisenhower Dr. Boulder CO 80302), Methods and apparatus for drug delivery using supercritical solutions.
  73. Kensil Charlotte A. (Milford MA) Soltysik Sean (Worcester MA) Marciani Dante J. (Hopkinton MA), Methods for enhancing drug delivery with modified saponins.
  74. Desai Neil P. (Los Angeles CA) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Grinstaff Mark W. (Pasadena CA) Suslick Kenneth S. (Champaign IL), Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful th.
  75. Day Delbert E. (Rolla MO) Ehrhardt Gary J. (Columbia MO), Microspheres for radiation therapy.
  76. Bastard Jean-Pierre (Lesigny FRX) Dupechez Thierry (Villemoisson sur Orge FRX) Fabre Jean-Louis (Paris FRX), New compositions containing taxane derivatives.
  77. Maione Theodore (Wakefield MA) Sharpe Richard J. (Newton MA), Novel methods and compositions for treatment of angiogenic diseases.
  78. Linhardt Robert J. (Iowa City IA) Weiler John M. (Iowa City IA), Oligosaccharide heparin fragments as inhibitors of complement cascade.
  79. Klein Larry L. (Lake Forest IL) Maring Clarence J. (Grayslake IL), Paclitaxel derivatives.
  80. Langley John G. (Leeds GB3) Symes Kenneth C. (Keighley GB3) Mistry Kishor K. (Bradford GB3) Chamberlain Peter (Shipley GB3), Particulate composition comprising a core of matrix polymer with active ingredient distributed therein.
  81. Iwaguchi Takao (Tokyo JPX) Shimamura Mariko (Tokyo JPX) Uchida Shingo (Yokohama JPX) Aoyagi Takaaki (Fujisawa JPX) Takeuchi Tomio (Tokyo JPX), Pharmaceutical composition and method for angiogenesis inhibition.
  82. Santus Giancarlo (Milan ITX) Bottoni Giuseppe (Bergamo ITX) Sala Giovanni (Verona ITX), Pharmaceutical controlled-release composition with bioadhesive properties.
  83. Shively Merrick L. (Louisville CO), Pharmaceutical solutions and emulsions containing taxol.
  84. Yokoyama Masayuki (Matsudo JPX) Sakurai Yasuhisa (Tokyo JPX) Okano Teruo (Ichikawa JPX) Kataoka Kazunori (Kashiwa JPX), Physical trapping type polymeric micelle drug preparation.
  85. Zalipsky Samuel (Princeton NJ) Bolikal Durgadas (Edison NJ) Nathan Aruna (Piscataway NJ) Kohn Joachim B. (Highland Park NJ), Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon.
  86. Casey Donald J. (Ridgefield CT) Rosati Louis (Norwalk CT), Polyesters containing alkylene oxide blocks as drug delivery systems.
  87. Amsden Brian G. (40 Fountainhead Rd. ; Apt. #1516 Downsview ; Ontario M3J 2V1 CAX) Cheng Yu-Ling (1399 Glenburnie Rd. Mississauga Ontario L5G 3C7 CAX), Polymer-based drug delivery system.
  88. Mongelli Nicola (Milan ITX) Angelucci Francesco (Milan ITX) Pesenti Enrico (Cologno Monzese ITX) Suarato Antonino (Milan ITX) Biasoli Giovanni (Gavirate ITX), Polymer-bound paclitaxel derivatives.
  89. Mongelli Nicola (Milan ITX) Angelucci Francesco (Milan ITX) Pesenti Enrico (Cologno Monzese ITX) Suarato Antonino (Milan ITX) Biasoli Giovanni (Gavirate ITX), Polymer-bound paclitaxel derivatives.
  90. Braatz James A. (Beltsville MD) Heifetz Aaron H. (Columbia MD), Polymer-modified peptide drugs having enhanced biological and pharmacological activities.
  91. Steuart Gary M. (98 Viking Terr. Northfield MN 55057) Huffstutler ; Jr. M. Conrad (6200 Lynn La. Lago Vista TX 78645), Polyphase fluid extraction process, resulting products and methods of use.
  92. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA), Preparation of multiwall polymeric microcapsules.
  93. Kuettner Klaus E. (Chicago IL) Eisenstein Reuben (Lincolnwood IL) Sorgente Nino (Los Angeles CA), Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor.
  94. Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GB2, Prevention and treatment of cardiovascular pathologies.
  95. Cohen Jonathan M. (Elmont NY) Siegel Ronald (Arlington Hts. MA) Langer Robert (Somerville MA), Process for making systems for the controlled release of macromolecules.
  96. Yamada Minoru (Kawanishi JPX) Ishiguro Seiko (Kawanishi JPX) Ogawa Yasuaki (Otokuni JPX), Prolonged release preparation and polymers thereof.
  97. Liu Sung-Tsuen (29 Landing Laguna Niguel CA 92677) Chung Harvey H. (43 Via Costa Verde Rancho Palos Verdes CA 90274), Resorbable bioactive calcium phosphate cement.
  98. Wang Taylor G. (Nashville TN), Semipermeable microspheres encapsulating biological material.
  99. Iwatsuki Makoto (Tokyo JPX) Hayashi Toshio (Kyoto JPX), Silk-fibroin and human-fibrinogen adhesive composition.
  100. Itoh Tetsuo (Shiga JPX) Matsuda Takehisa (Minoo JPX), Surgical adhesive.
  101. Rawlings David A. (Stansted Mountfitchet GB3) Potter William D. (Bishops Stortford Hertfordshire GB3), Surgical dressing.
  102. Baichwal Anand R. (Wappingers Falls NY), Sustained release heterodisperse hydrogel systems for insoluble drugs.
  103. McClelland Gregory A. (Lawrence KS) Zentner Gaylen M. (Lawrence KS), Swelling modulated polymeric drug delivery device.
  104. Folkman Moses J. (Brookline MA) Langer ; Jr. Robert S. (Allston MA), Systems for the controlled release of macromolecules.
  105. Bobee Jean-Marc (Verrieres-le-Buisson FRX) de Lanty Patrick (Paris FRX) Guerin Gilles (Eaubonne FRX) Veillard Michel (Sceaux FRX), Taxoid-based compositions.
  106. Straubinger Robert M. (Amherst NY) Sharma Amarnath (Buffalo NY) Mayhew Eric (South Wales NY), Taxol formulation.
  107. Nakao Hiroshi (Tuchiura JPX) Nagoya Takao (Tuchiura JPX) Saino Yushi (Tokyo JPX), Therapeutic agent for skin or corneal disease.
  108. Kohn Elise C. (Olney MD) Liotta Lance A. (Potomac MD), Therapeutic application of an anti-invasive compound.
  109. Kunz Lawrence L. ; Klein Richard A. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  110. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2 ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  111. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  112. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  113. Ali Yusuf (Forth Worth TX) Reed Kenneth W. (Lawrenceville GA), Topical ophthalmic pharmaceutical vehicles.
  114. Langer Robert S. (Somerville MA) Kost Joseph (Brookline MA), Ultrasonically modulated polymeric devices for delivering compositions.
  115. Domb Abraham J. (Brookline MA) Langer Robert S. (Somerville MA), Unsaturated polyanhydrides.
  116. Deutch Alan H. (Columbia MD) Tuszynski George P. (Williamstown NJ), Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity.
  117. Kingston David G. I. (Blacksburg VA) Zhao Zhi-Yang (Kalamazoo MI), Water soluble derivatives of taxol.
  118. Nicolaou K. C. (La Jolla CA) Riemer Claus G. (Schliengen DEX) Kerr Michael A. (Wolfville CAX), Water soluble taxol derivatives.
  119. Haugwitz Rudiger D. (Bethesda MD) Zalkow Leon (Atlanta GA) Glinski Jan (Ridgefield CT) Suffness Mathew (Silver Spring MD) Deutsch Howard M. (Atlanta GA) Narayanan Venkatachala (Gaithersburg MD), Water soluble, antineoplastic derivatives of taxol.
  120. Igari Yasutaka (Kobe JPX) Yamada Minoru (Kawanishi JPX) Ishiguro Seiko (Kawanishi JPX), Water-soluble composition for sustained-release.

이 특허를 인용한 특허 (108)

  1. Heitzmann, Harold; Tasso, Vanessa, Anterior chamber drug-eluting ocular implant.
  2. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  3. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  4. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  5. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  6. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  7. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  8. Chudzik,Stephen J.; Anderson,Aron B.; Chappa,Ralph A.; Kloke,Timothy M., Bioactive agent release coating.
  9. Chudzik,Stephen J.; Anderson,Aron B.; Chappa,Ralph A.; Kloke,Timothy M., Bioactive agent release coating.
  10. Chappa, Ralph A.; Hergenrother, Robert W.; Anderson, Aron B.; Tran, Linh V.; Lawin, Laurie R.; Ofstead, Ronald F., Bioactive agent release coating and controlled humidity method.
  11. Ornberg,Richard; Udipi,Kishore; Forster,Denis; Riley,Dennis; Thurmond,Bruce; Henke,Susan; Brethauer,Kerry, Biomaterials modified with superoxide dismutase mimics.
  12. Ornberg,Richard L.; Udipi,Kishore; Forster,Denis; Riley,Dennis P.; Thurmond,Kenneth B.; Henke,Susan; Brethaur,Kerry; Joardar,Saikat, Biopolymers modified with superoxide dismutase mimics.
  13. Concagh, Danny; Cheng You, Chang; Zugates, Greg, Bioresorbable thermoset polyester/urethane elastomers.
  14. DeWitt, David M.; Finley, Michael J.; Lawin, Laurie R., Coating compositions for bioactive agents.
  15. DeWitt, David M.; Finley, Michael J.; Lawin, Laurie R., Coating compositions for bioactive agents.
  16. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same.
  17. Ventura, Joseph; Wadman, Shannon; Slager, Joram; McGonigle, Joseph Schmidt; Hergenrother, Robert W., Composition and method for delivery of hydrophobic active agents.
  18. Ventura, Joseph; Wadman, Shannon; Slager, Joram; McGonigle, Joseph Schmidt; Hergenrother, Robert W., Composition and method for delivery of hydrophobic active agents.
  19. Hunter, William L.; Gravett, David M.; Toleikis, Philip M.; Liggins, Richard T.; Loss, Troy A. E., Compositions and methods for coating medical implants.
  20. Hunter, William L.; Gravett, David M.; Toleikis, Philip M.; Liggins, Richard T.; Loss, Troy A. E., Compositions and methods for coating medical implants.
  21. Hunter, William L; Gravett, David M; Toleikis, Philip M; Liggins, Richard T; Loss, Troy A. E., Compositions and methods for coating medical implants.
  22. Reb, Philippe, Compositions and methods using microspheres and non-ionic contrast agents.
  23. Reb, Philippe, Compositions and methods using microspheres and non-ionic contrast agents.
  24. Reb, Philippe, Compositions and methods using microspheres and non-ionic contrast agents.
  25. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  26. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  27. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  28. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  29. Slager, Joram, Delivery of coated hydrophobic active agent particles.
  30. Slager, Joram, Delivery of coated hydrophobic active agent particles.
  31. Slager, Joram; Heyer, Toni M.; Babcock, David E., Delivery of hydrophobic active agent particles.
  32. Slager, Joram; Heyer, Toni M.; Babcock, David E., Delivery of hydrophobic active agent particles.
  33. Schüssler, Andreas; Grunze, Michael; Denk, Roman, Device based on nitinol, a process for its production, and its use.
  34. Chappa, Ralph A.; Bach, Andrew G., Devices and methods for delivery of bioactive agents.
  35. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  36. Shanley,John F.; Parker,Theodore L., Drug delivery device and method for bi-directional drug delivery.
  37. Palasis, Maria; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kirchel; Sharma, Upma; Zugates, Gregory T., Drug eluting medical implant.
  38. Palasis, Maria; You, Changcheng; Concagh, Danny; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Gregory T., Drug eluting medical implant.
  39. Haffner, David; Curry, Ken; Heitzmann, Harold; Applegate, David, Drug eluting ocular implant.
  40. Shanley, John F., Expandable medical device delivery system and method.
  41. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  42. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  43. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  44. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
  45. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
  46. Shanley,John F., Expandable medical device for delivery of beneficial agent.
  47. Shanley,John F.; Eigler,Neal L.; Park,Kinam; Edelman,Elazer R., Expandable medical device for delivery of beneficial agent.
  48. Shanley, John F., Expandable medical device with S-shaped bridging elements.
  49. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
  50. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
  51. Shanley, John F., Expandable medical device with ductile hinges.
  52. Shanley, John F.; Eigler, Neal L.; Edelman, Elazer R., Expandable medical device with improved spatial distribution.
  53. Shanley, John F.; Eigler, Neal L.; Edelman, Elazer R., Expandable medical device with improved spatial distribution.
  54. Shanley, John F., Expandable medical device with tapered hinge.
  55. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix for intraluminal drug delivery.
  56. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery.
  57. Von Oepen, Randolf; Stankus, John; Stamberg, Barbara; Yribarren, Travis R.; Newhauser, Richard R., Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery.
  58. Shanley, John F.; Parker, Theodore L.; Park, Kinam, Implantable medical device with beneficial agent concentration gradient.
  59. Shanley,John F.; Parker,Theodore L., Implantable medical device with drug filled holes.
  60. Haffner, David S.; Burns, Thomas W.; Heitzmann, Harold A.; Curry, Kenneth M., Implants with controlled drug delivery features and methods of using same.
  61. Haffner, David S.; Burns, Thomas W.; Heitzmann, Harold A.; Curry, Kenneth M., Implants with controlled drug delivery features and methods of using same.
  62. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same.
  63. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same.
  64. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  65. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  66. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  67. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  68. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  69. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  70. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  71. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  72. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  73. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  74. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  75. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  76. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  77. Chappa, Ralph A., Medical devices and methods for producing the same.
  78. Busold, Rany; You, Chang cheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Palasis, Maria; Sharma, Upma; Zugates, Greg, Medical implant.
  79. Busold, Rany; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Palasis, Maria; Sharma, Upma; Zugates, Greg, Medical implant.
  80. Palasis, Maria; Cheng You, Chang; Concagh, Daniel; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Greg, Medical implant.
  81. Palasis, Maria; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Gregory T., Medical implants.
  82. Scheuermann, Torsten; Stehling, Lutz, Metal stent with surface layer of noble metal oxide and method of fabrication.
  83. Scheuermann,Torsten; Stehling,Lutz, Metal stent with surface layer of noble metal oxide and method of fabrication.
  84. Diaz, Stephen Hunter; Park, Kinam, Method and apparatus for loading a beneficial agent into an expandable medical device.
  85. Diaz, Stephen Hunter; Park, Kinam, Method and apparatus for loading a beneficial agent into an expandable medical device.
  86. Shanley, John F.; Diaz, Stephen Hunter, Method and apparatus for loading a beneficial agent into an expandable medical device.
  87. Davalian, Dariush, Method for the manufacture of stable, nano-sized particles.
  88. Davalian, Dariush, Method for the manufacture of stable, nano-sized particles.
  89. Vogel, Jean-Marie; Boschetti, Egisto, Methods of using microspheres for active embolization.
  90. Jackson, John K.; Zastre, Jason; Burt, Helen M., Micellar drug delivery systems for hydrophobic drugs.
  91. Vogel, Jean-Marie; Boschetti, Egisto, Microspheres for active embolization.
  92. Grunze,Michael; Gries,Claudia, Poly-tri-fluoro-ethoxypolyphosphazene coverings and films.
  93. Douk, Nareak; Busold, Rany; Core, Lee; Ho, Kicherl; Le, My, Polymeric implant delivery system.
  94. Ruane, Patrick H., Post-processing of a medical device to control morphology and mechanical properties.
  95. Scheuermann, Torsten; Alt, Eckhard, Primarily niobium stent.
  96. Scheuermann,Torsten; Alt,Eckhard, Primarily niobium stent.
  97. Huang, Bin; Kleiner, Lothar W.; Stankus, John, Stent and delivery system with reduced chemical degradation.
  98. Huang, Bin; Kleiner, Lothar W.; Stankus, John, Stent and delivery system with reduced chemical degradation including a Chitooligosaccharide.
  99. Kavteladze, Zaza Alexandrovich, Stent and stent retrieval system and a method of pulling a stent into tubular member.
  100. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John, Stent delivery system having a fibrous matrix covering with improved stent retention.
  101. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John J., Stent delivery system having a fibrous matrix covering with improved stent retention.
  102. Shanley,John F., Stent wall structure.
  103. Shanley,John F., Stent wall structure.
  104. Grunze, Michael; Fritz, Ulf, Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface.
  105. Grunze, Michael, Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface.
  106. Shanley, John F.; Parker, Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
  107. Shanley,John F.; Parker,Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
  108. Haffner, David; Curry, Kenneth, Uveoscleral drug delivery implant and methods for implanting the same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로